Printer Friendly

GENSIA APPOINTS MARTHA HOUGH VICE PRESIDENT OF PLANNING & ADMINISTRATION

 GENSIA APPOINTS MARTHA HOUGH VICE PRESIDENT
 OF PLANNING & ADMINISTRATION
 SAN DIEGO, Jan. 16 /PRNewswire/ -- Gensia Pharmaceuticals Inc. (NASDAQ: GNSA) today announced that Martha L. Hough has been appointed vice president of planning & administration. She was appointed corporate secretary in August 1991. Hough has responsibility for investor relations, corporate communications, strategic planning and human resources administration, according to David F. Hale, chairman, president and chief executive officer.
 Hough has been employed with Gensia since August 1987 as director and senior director of planning & administration. Prior to joining Gensia, Hough was vice president of Sorrento Associates Inc., a San Diego-based investment banking and venture capital firm. She also worked in strategic planning and as a financial manager for General Mills Inc. in corporate headquarters and in two operating subsidiaries. Hough received her master's degree in business administration from the Amos Tuck School of Business Administration at Dartmouth College and a bachelor of science degree with highest distinction from Colorado State University.
 "Martha has been an integral member of the financial planning and administration group in her tenure with Gensia," said Hale. "Her previous training in corporate finance, strategic planning and administrative management has been important in supporting Gensia's rapid growth. This promotion recognizes her contributions and is part of our continuing program to build Gensia's management team for the future."
 Gensia Pharmaceuticals is a San Diego-based bisis of human diseases.
 -0- 1/16/92
 /CONTACT: David F. Hale, chairman, president & CEO of Gensia Pharmaceuticals Inc., 619-546-8300; or Linda C. Seaton of The Gable Group, 619-234-1300, for Gensia Pharmaceuticals Inc./
 (GNSA) CO: Gensia Pharmaceuticals Inc. ST: California IN: MTC SU: PER


DM-JL -- SD003 -- 0608 01/16/92 14:37 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 16, 1992
Words:277
Previous Article:CONVENTIONAL AIR LAUNCHED CRUISE MISSILE ANNOUNCEMENT
Next Article:WEST ONE BANCORP INCREASES DIVIDEND
Topics:


Related Articles
NICHOLAS YEO JOINS GENSIA EUROPE LTD. AS DIRECTOR OF MARKETING - EUROPE
GENSIA AND ALLERGAN ENTER INTO RESEARCH AGREEMENT IN OPHTHALMIC DISEASE
GENSIA AND ALLERGAN ENTER INTO RESEARCH AGREEMENT IN OPHTHALMIC DISEASE
GENSIA ADOPTS STOCKHOLDER RIGHTS PLAN; APPOINTS CARL BOBKOSKI TO BOARD
GENSIA HIRES NEW RESEARCH DIRECTORS IN CENTRAL NERVOUS SYSTEM PHARMACOLOGY AND IMMUNOLOGY
GENSIA TO PROCEED AS PLANNED WITH ARASINE REGULATORY FILINGS IN UNITED STATES AND EUROPE
GENSIA EUROPE LTD. APPOINTS STEWART SIDDALL TO BOARD OF DIRECTORS
GENSIA APPOINTS HERBERT CONRAD TO BOARD OF DIRECTORS
ARAMED NAMES NEW MEMBERS OF BOARD OF DIRECTORS
Gensia Sicor Announces Management Appointments

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters